I am an Assistant Professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute. I am in the Division of Child Health Research and Policy (CHeRP) and the Precision Medicine Translational Research (PROMoTeR) Center and am a Member of the HMS Center for Bioethics.
My research program evaluates the clinical, patient-centered, and economic outcomes of genomic medicine. As a health economist and a scholar in the ethical, legal, and social implications (ELSI) of genomics, I develop approaches to integrate and advance health economic and ELSI research in genomics. I aim to produce evidence that informs decision making by clinicians, patients and families, and health care systems to ensure efficient and ethical implementation of genomic technologies in clinical care.
I am currently funded on a K99/R00 Pathway to Independence Career Development Award from the National Human Genome Research Institute to study the family-level utility of pediatric genomic sequencing using a patient-centered approach and decision science methods. I am also the Project Director of the Precision Medicine Policy and Treatment Model (PreEMPT II) and a co-Investigator on the BabySeq Project, a randomized controlled trial of newborn genomic sequencing. My research has been published in JAMA Pediatrics, Nature Genetics, The American Journal of Human Genetics, and Genetics in Medicine. I am a section editor for Economics and Precision Medicine at Genetics in Medicine.